PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

1.52
-0.100   -6.579%

Share volume: 9,413,304
Last Updated: 03-03-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$1.62
-0.10
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 15%
Dept financing 16%
Liquidity 52%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.52%
1 Month
-22.05%
3 Months
-39.68%
6 Months
22.58%
1 Year
12.59%
2 Year
-68.85%
Key data
Stock price
$1.52
P/E Ratio 
0.00
DAY RANGE
$1.49 - $1.57
EPS 
-$1.82
52 WEEK RANGE
$0.85 - $2.73
52 WEEK CHANGE
$13.43
MARKET CAP 
564.567 M
YIELD 
N/A
SHARES OUTSTANDING 
301.998 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
1.19
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,850,343
AVERAGE 30 VOLUME 
$6,858,225
Company detail
CEO: Christian O. Henry
Region: US
Website: pacb.com
Employees: 730
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.

Recent news